Loading...
SANM is not a good buy right now for an impatient trader. The stock is in a sharp post-earnings downtrend on weak guidance, momentum is still bearish (negative/expanding MACD), and there are no Intellectia buy signals to override the setup. While it’s near first support (~144.7) and options positioning is call-heavy (bullish tilt), the near-term catalyst is still negative (guidance reset + uncertainty), so the odds favor more choppy downside/volatility before a cleaner entry emerges.
Price/Trend: SANM is selling off hard (regular session -6.11% and pre-market -4.81%), indicating a strong bearish impulse immediately after earnings/guidance. Momentum: MACD histogram is -3.071 and negatively expanding, confirming downside momentum is accelerating rather than stabilizing. RSI: RSI(6) at ~31.3 is near oversold territory (not yet a confirmed reversal signal by itself), implying bounces are possible but not reliable without momentum improvement. Moving averages: Converging MAs suggest the prior trend is losing structure, but this is not yet a bullish turn—more consistent with a transition into a volatile consolidation after a breakdown. Levels: Key near-term support is S1 ~144.728 (current price ~145.6 is sitting just above it). A clean break below S1 opens room toward S2 ~133.379. Overhead resistance is heavy: pivot ~163.096, then R1 ~181.464.
Intellectia Proprietary Trading Signals

and revenue surged (+58.98% YoY to ~$3.19B), signaling strong top-line momentum.
means a breakdown could quickly target the low-130s (S2 ~133.4).
Latest quarter (FY2026 Q1): Revenue grew strongly to ~$3.189B (+58.98% YoY), but profitability weakened: net income fell to ~$49.3M (-24.18% YoY) and EPS fell to $0.89 (-23.28% YoY). Gross margin slipped to ~7.56% (down ~9.68% YoY). Bottom line: strong top-line expansion paired with margin/EPS erosion—this is a mixed quality quarter and helps explain why the market sold the stock on guidance despite the revenue beat.
Recent trend: Price targets have moved up, while ratings are mixed-to-positive. Argus (2026-01-28) reiterated Buy and raised PT to $200 (from $170) after the Q1 beat, citing strong footprint and limited tariff impact. BofA (2026-01-22) kept Neutral but raised PT to $190 (from $180), balancing improving communications demand and ZT’s rack capability against macro uncertainty and integration/ramp risk; BofA also raised PT earlier (2025-11-04) to $180 while staying Neutral. Wall Street pros: scale/footprint, demand normalization in comms, and optionality from ZT + rack builds. Cons: guidance uncertainty, margin pressure, and execution risk integrating ZT and transitioning rack revenue sources. Politicians/Congress: No recent congress trading data available; hedge funds/insiders show no significant recent trend (both neutral).